WASHINGTON (AP) — Makers of medical tests that have long escaped government oversight will have about four years to show that their new offerings deliver accurate results, under a government rule vigorously opposed by the testing industry.
The regulation finalized Monday by the Food and Drug Administration will gradually phase in oversight of new tests developed by laboratories, a multibillion-dollar industry that regulators say poses growing risks to Americans. The goal is to ensure that new tests for cancer, heart disease, COVID-19, genetic conditions and many other illnesses are safe, accurate and reliable.
“The final rule announced today aims to provide crucial oversight of these tests to help ensure that important health care decisions are made based on test results that patients and health care providers can trust,” said FDA commissioner Robert Califf, in a release.
Related articles:
Related suggestion:
China eases past Myanmar to reach last 16 in Asiad men's football eventArt reshapes rural scene in SW China villageThrifty Asian Games puts spring in the step of rural studentsGreater choice gives tourism sector a boostConfucius, or the Science of the Princes: key to better understanding SinoA monument to heroesChina beats Philippines at Asian Women's Volleyball ChampionshipZheng Qinwen stopped in U.S. Open quarterfinals, Wang Xinyu into doubles semisHolistic pursuit of national security lays solid groundwork for China's rejuvenation causeCanton Fair opens in China with surge in overseas purchasers
2.7853s , 6499.328125 kb
Copyright © 2024 Powered by FDA brings lab tests under federal oversight in bid to improve accuracy and safety ,Global Gazetteer news portal